Additionally, among AMD patients, genetic polymorphisms in VEGFA (rs3025000, 833069, and rs699947) [37,39,40,41], NRP1 (rs2070296) [42], and CXCL8 (rs4073) [27] are associated with interindividual differences in the response to ranibizumab. The gene discussed is CXCL8; the disease is age-related macular degeneration.